Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,432
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.5%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 451–500 of 1,781 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03565783	Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery	active not recruiting	Phase 2	44	M.D. Anderson Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials
NCT03690986	VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer	active not recruiting	Phase 1	35	Emory UniversityOTHER	1	Jul 16, 2026	clinicaltrials